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protein expression of left ventricular tissues was detected using q-PCR
and western blot analysis that are associated with oxidative stress.
RESULTS AVE 0991 displayed a signiﬁcant reduction in the left ven-
tricular weight (15.960.68 vs. 22.210.75, P < 0.01) and left ventric-
ular end-diastolic diameter (3.480.19 vs. 4.320.20, P < 0.05), and a
signiﬁcant elevation in left ventricular ejection fraction (58.162.78
vs. 41.825.58, P < 0.05) when compared to the vehicle-treated AB
group. Moreover, we found that the mean myocyte diameter (13.53
0.56 vs. 15.46  0.21, P < 0.01) and the gene expression of the hy-
pertrophic markers atrial natriuretic peptide (ANP) (P < 0.01) and b-
MHC (P < 0.01) were markedly decreased in the AVE0991 group.
Furthermore, AVE 0991 inhibited the mRNA and protein expression of
NOX 2 (P < 0.01) and NOX 4 (P < 0.01) when compared to the vehicle-
treated AB group.
CONCLUSIONS Our data showed that AVE 0991 treatment could
attenuate cardiac hypertrophy and improve heart function, which
may be attributed to reducing the oxidative stress.
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OBJECTIVES Maternal nicotine exposure caused alteration of gene
expression patterns and programming of cardiovascular dysfunction.
This study was to investigate effect of nicotine on cardiac gene
expression and epigenetic regulation during cardiac myogenesis.
METHODS To study effect of nicotine on cardiac myogenesis, in vitro
and in vivo cardiac developmental model were established respec-
tively. Mouse embryonic bodies (EBs) derived from mouse embryonic
stem cells were induced to 12-day cardiac differentiation with or
without nicotine treatment. As in vivo cardiac myogenic model,
pregnant Sprague–Dawley rats were exposed to nicotine through
gestation, hearts were isolated from neonatal offspring for further
molecular study after echocardiography for heart function.
RESULTS In vitro study shows nicotine exposure selectively inhibited
expression of two cardiac genes (GATA4 and Tbx5) in both mRNA and
protein expression level. Persistent nicotine exposure resulted in up-
regulation of 5-methylcytosine, DNMT1 and DNMT3A but decreased
GATA4 and Tbx5 gene expression due to promoter DNA hypermethylation.
However, no signiﬁcant effect has been found on mESCs proliferation and
two embryonic biomarkers’(Oct4 and Nanog) mRNA expression with
nicotine treatment. Nicotine exposure also decreased amounts of beating
EBs and reduced GATA4 positive cells at 12-day EBs. This nicotine-induced
suppression was reversed by general nicotinic acetylcholine receptors
(nAChRs) inhibitor, suggesting the involvement of nAChRs in the direct
adverse impact of nicotine on cardiac differentiation. Consistent results of
GATA4 and Tbx5 gene suppression and promoter DNA hypermethylation
by maternal nicotine treatment were obtained from in vivo cardiac
development model. Echocardiography showed impaired cardiac function
in offspring including reduced ejection fraction (EF%), systolic and dia-
stolic left ventricular anterolateral wall (LVAW;s and LVAW;d) as well as
systolic and diastolic left ventricular posterior wall (LVPW;s and LVPW;d).
CONCLUSIONS This study presents a direct repressive effect of
nicotine on cardiac transcriptional factors (GATA4 and Tbx5) by pro-
moter DNA hypermethylation during cardiac myogenesis. Reduction
of spontaneous beating EBs and impaired cardiac function in offspring
heart has been found with nicotine exposure.
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OBJECTIVES Timothy syndrome (TS) is a malignant form of congen-
ital long QT syndrome with excessive cellular Ca2þ entry and torsadede pointes (TdP) arrhythmias often triggered by a variety of neuro-
hormonal and second-massager pathways. We sought to explore
mechanisms by which Ca2þ/ calmodulin-dependent protein kinase
(CaMKII) modulates arrhythmogenesis and to identify potential tar-
geted sites of antiarrhythmic therapy in TS arising from a novel mu-
tation (CACNA1C, p.G1911R).
METHODS A 15 mm15 mm two-dimensional (2D) multicellular
transmural tissue model was developed by integrating an anatomi-
cally ventricular geometry of the human ventricular tissue sheet and a
dynamic human ventricular myocyte model incorporated with a
detailed CaMKII module in the format of mono-domain model. To
better understand the TS, L-type Ca2þ current (ICaL) equations of the
myocyte model were modiﬁed based on experimental conditions
(current density increasedw20%, V1/2 of activation shiftedw-5mV, V1/2
of inactivation shifted wþ6 mV, tau of inactivation increased w20%).
To explore ionic mechanisms of CaMKII-dependent TdP, proar-
rhythmic substrates were compared and analyzed. In addition, in
order to investigate mechanisms initiating and maintaining TdP, the
spatial organization of repolarization and arrhythmogenesis were
determined in the 2D transmural tissue model.
RESULTS TS ventricular myocytes exhibited more activated
CaMKII(w50%), increased ICaL facilitation (w55%), higher peak Ca2þ
transient (w83%), augmented frequency of Ca2þ sparks (w200%),
enhanced maximum SR Ca2þ content (w34%), prolonged action po-
tential duration (APD) and afterdepolarizations. On the one hand,
CaMKII-dependent SR overload resulted in SR Ca2þ leak for triggering
delayed afterdepolarizations (DADs); on the other hand, CaMKII-
dependent ICaL facilitation contributed to excessive action potential
prolongation in midmyocardial (M) cells (from 413.6 to 1133.9 ms)
which favors the generation of early afterdepolarizations(EADs). The
excessive prolongation of APD in the M cells caused an abrupt rise in
transmural dispersion of repolarization (from 33.06 ms/mm to 52.99
ms/mm) and M cells formed zones of increased refractoriness, pro-
ducing steep spatial gradients of repolarization that were directly
responsible for conduction block and self-sustained intramural reen-
trant circuits underlying TdP. However, CaMKII inhibition reversed
an increase in intracellular Ca2þ, normalized action potential and
prevented TdP.
CONCLUSIONS These computer simulations suggest that TS-medi-
ated Ca2þ inﬂux is an upstream initiating event for arrhythmia phe-
notypes that are ultimately dependent on CaMKII activation, the M
region of TS can increase intrinsic heterogeneities of cardiac tissue
and resulte in the generation and maintenance of reentrant excita-
tions underlying TdP, and CaMKII blockers may provide additional
antiarrhythmic effect in patients with TS.GW26-e4017
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OBJECTIVES Drag-reducing polymers (DRPs) are blood-soluble mac-
romolecules that can increase blood ﬂow and reduce vascular resis-
tance. It has been widely used in petroleum transportation, irrigation,
navigation and other industrial pipeline. In recent years, the potential
medical application of DRPs had been explored in cardiovascular
disease, atherosclerosis, shock and other ﬁelds. The purpose of the
present study is to observe the effect of DRPs on myocardial ischemia/
reperfusion (I/R) injury in rat model.
METHODS Adult Wistar rats were randomly divided into three groups
(n¼16): DRP group, Control group and Sham group. Acute myocardial
infarction achieved by occluding left anterior descending coronary
artery (LAD). After 30 min of ischemia, the LAD was released 120 min
to induce I/R injury. Sham animals underwent left thoracotomy only.
Rats in DRP group were injected with 510-5 g/ml DRP solution
through the right jugular vein at a constant rate of 3.5 ml/h for 30 min
during reperfusion. Saline was administered in control group and
sham group. Ejection fraction was measured by echocardiography
after 120 min reperfusion. A catheter inserted into left ventricle to
measure left ventricular systolic pressure (LVSP) and left ventricular
end-diastolic pressure (LVEDP). Myocardial infarct size were also been
measured.
RESULTS All rats in sham group survived through 150 min observa-
tion period, the survival rate in DRP group was 81.25% (13/16),
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and reperfusion, DRP treatment signiﬁcantly increased ejection frac-
tion in this study (DRP group: 40.17.2%; Control group: 27.89.1%;
Sham group: 53.77.6%; P<0.01). Our results showed that DRP
decreased LVEDP and increased LVSP in DRP group compared
with the control group (LVEDP: DRP group 13.468.54 mmHg vs.
Control group 26.2313.12 mmHg vs. Sham group 4.835.42 mmHg,
P<0.01; LVSP: DRP group 87.7112.68 mmHg vs. Control group
69.9011.08 mmHg vs. Sham group 113.2416.76 mmHg, P<0.05).
Myocardial infarct size was signiﬁcantly decreased in DRP group
compared with that in the control group (DRP group: 22.038.67%;
Control group: 29.5411.36%; Sham group: 0.000.00%; P<0.01).
CONCLUSIONS These results suggested that DRPs had a protective
effect on cardiac I/R injury of rat hearts and it may offer a
new potential approach for the treatment of acute ischemic heart
diseases.
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OBJECTIVES To explore the roles of p38MAPK in diabetic cardiomy-
opathy. To investigate wheather Naringin protects cardiomyocytes
against diabetic cardiomyopathy through inhibiting p38MAPK
pathway.
METHODS The 60 male SD rats were randomly divided into normal
control group (10 rats), model group (50 rats). Diabetic rats induced by
high-sugar and high fat diet and intraperitoneal injection of strepto-
zotocin. Naringin (20/40/80 mg$kg-1$d-1) and SB203580 were
administered in diabetic rats for six weeks. Blood glucose were
detected every 2 weeks, expression of myocardial t-p38MAPK and p-
p38MAPK were tested by Western blotting Assay. Serum BNP were
assayed using ELISA kit. Morphology of myocardial cell and myocar-
dial structure were observed by light microscopy and electron
microscopy.
RESULTS Naringin could lower blood glucose, BNP and heart to
weight index in STZ-induced diabetic cardiomyopathy rat.
Morphology of myocardial cell and myocardial structure were
analyzed through light microscopy and electron microscopy, which
were improved by naringin treatment. Compared with the normal
control group, the p-p38MAPK expression of myocardial tissue in DCM
rats treated by naringin were decreased similar to the inhibitory effect
of a p38MAPK inhibitor SB203580.
CONCLUSIONS Naringin could effectively prevent myocardial
remodeling and improve cardiac function via inhibiting p38MAPK
pathway.
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OBJECTIVES Mobilization and homing of bone-marrow mesenchymal
stem cells (BMSCs) were observed in acute myocardial ischemic
injury, but disappeared in a long-term ischemic stress along with
depressed copper (Cu) concentrations in the heart. Cu is required for
hypoxia-inducible transcription factor-1 (HIF-1) regulation of expres-
sion of BMSC homing factors. The present study was to test the hy-
pothesis that Cu supplementation recovers BMSC homing signaling
system, leading to BMSC homing to the chronic ischemic infarct area
of heart.
METHODS Male adult New Zealand rabbits were subjected to coronary
artery ligation to generate myocardial ischemia. Six months after
myocardial ischemia, a newly developed ultrasound contrast micro-
bubble composed of Cu-albumin surfaced structure was used to spe-
ciﬁcally deliver Cu to the infarct area. The autologous BMSCs were
labeled with ﬂuorescence and injected via i.v. to the rabbits 24 hours
before the heart harvest. AMD3100, the speciﬁc SDF-1/CXCR4 axis
blocker, was used to treat the labeled BMSCs in one group.RESULTS BMSCs signaling was observed within 7 days after myocar-
dial ischemia and identiﬁed in the ischemic area; but six month after
myocardial ischemia, the labeled cells were not found in the ischemic
area. The ultrasound-Cu-delivering led to homing of the labeled
BMSCs to the chronic ischemic infarct area. AMD3100 blocked the
recovery of Cu-microbubble-induced homing of BMSCs.
CONCLUSIONS This study thus demonstrated that Cu supplementa-
tion reestablishes the signaling pathways for homing of BMSCs to the
chronic ischemic area, which involves the role of Cu-activated HIF-1
transcriptional activity.
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OBJECTIVES The recent discovery of the new components of the
renin-angiotensin system (RAS) suggests the importance of the
maintenance of cardiovascular structure and functions. To assess the
role of the ACE2-Mas axis in the regulation of cardiac structure and
function, the present work investigated the expression of ACE2 and
Mas receptor in the heart in the cardiac remodelling that occurs in
aortic constricted rats.
METHODS Partial abdominal aortic ligation was carried out in Spra-
gue-Dawley rats. Angiotensin AT1 receptor blockade and ACE inhibi-
tion were achieved by losartan and enalapril treatment, respectively.
RESULTS Results showed that aortic constriction increased left
ventricular hypertrophy, ﬁbrosis, MAP, plasma renin activity (PRA)
and cardiac ACE levels, but decreased the expression of cardiac
ACE2 and Mas receptor. Losartan treatment signiﬁcantly decreased
MAP, left ventricle hypertrophy (LVH), ﬁbrosis, and increased car-
diac ACE2 and Mas expression. Enalapril also improved the cardiac
parameters with a rise in cardiac ACE2, but did not change the Mas
level.
CONCLUSIONS Aortic constriction results in cardiac hypertrophy,
ﬁbrosis and a rise of cardiac ACE expression. Both AT1 receptor
blocker and ACE inhibitor play a cardioprotective role in aortic
constriction. However, AT1 receptor blocker particularly promotes
cardiac ACE2 and Mas receptor levels. ACE inhibitor is associated with
the inhibition of ACE and normalization of cardiac ACE2 activity.
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OBJECTIVES We tested the hypothesis that low level electromagnetic
ﬁeld (EMF) could suppress intermittent hypoxia induced atrial ﬁbril-
lation (AF) through autonomic modulating.
METHODS Electrode catheters were attached to atria, and all pulmo-
nary veins. Helmholtz coils were powered by a function generator
inducing an EMF. The ventilators were adjusted to simulate the
intermittent hypoxia for 1 hour as an acute intermittent hypoxia
model. Programmed stimulation determined the effective refractory
period (ERP) and the window of vulnerability (WOV), a measure of AF
inducibility. 40 ms of high-frequency stimulation (HFS; 100 Hz, 0.01
ms pulse width) was delivered 2 ms after atrial pacing (during the
refractory period) to determine the AF threshold (AF-TH) at each site.
Other electrodes were attached to the superior left ganglionated plexi
(SLGP) and left stellate ganglion (LSG) so that HFS (20 Hz, 0.1 ms pulse
width) to these sites induced SR slowing and blood pressure (BP)
elevation, respectively. Neural activities recorded from the SLGP, LSG
and Renal sympathetic nerve (RSN).
RESULTS
(1) Intermittent hypoxia induced a increase in WOV, a decrease in
AF-TH and ERP at all sites (all P < 0.05).
(2) The SR slowing response induced by SLGP stimulation and BP
elevation induced by LSG stimulation were facilitated by 1 hour
intermittent hypoxia.
